Viewing Study NCT00967512


Ignite Creation Date: 2025-12-26 @ 10:17 PM
Ignite Modification Date: 2026-05-09 @ 3:13 PM
Study NCT ID: NCT00967512
Status: WITHDRAWN
Last Update Posted: 2014-09-18
First Post: 2009-08-26
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Aezea® (Cenersen) and Chemotherapy for AML Subjects ≥ 55 Years of Age With No Response to Frontline Induction Course
Sponsor: Eleos, Inc.
Organization:

Organization Data

Organization:
Class: INDUSTRY
Study ID: ELP1020
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators